Wound and Tissue Management Market Size, Share, and Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Wound Closure Market, Traditional Wound Dressing Market, and 11 more
In 2023, the U.S. wound and tissue management market was valued at $12.2 billion, with expectations for it to grow at a 3.9% CAGR, reaching $15.9 billion by the end of the forecast period. The full report on this market encompasses a wide range of segments, including wound closure, traditional and advanced wound dressings (such as moist, antimicrobial, interactive, and non-adherent contact layers), surgical hemostats, tissue sealants, anti-adhesion products, negative pressure wound therapy (NPWT), static compression therapy, and dynamic compression therapy.
DATA COVERED IN THE REPORT:
Unit Sales, Pricing Trends, and Market Growth
Projections to 2030 and Historical Insights from 2020
Key Drivers and Restraints by Segment
Competitive Landscape with Market Share Breakdown
Recent Mergers & Acquisitions
Procedure Volumes
Competitor Profiles, Product Portfolios, and SWOT Analysis for Leading Companies
Impact of COVID-19
U.S. WOUND AND TISSUE MANAGEMENT MARKET TRENDS:
While most wound and tissue management segments are experiencing growth, the market faces challenges due to the availability of alternative wound care options. Traditional wound dressings are increasingly being replaced by advanced products, although even within the advanced segment, some dressings are outperformed by newer methods tailored to specific wound types
.U.S. WOUND AND TISSUE MANAGEMENT MARKET LEADERS:
Three major companies dominate the U.S. wound and tissue management market: Ethicon, 3M, and Medtronic.
Ethicon holds the top position, primarily due to its leading role in wound closure, representing over 25% of the total market. Additionally, Ethicon has a strong presence in surgical hemostats, anti-adhesion, and tissue sealants, with steady growth expected in these sectors.
3M ranks second, driven by its dominant 75%+ market share in NPWT and significant stake in advanced wound dressings. Both segments are anticipated to grow at a 4-5% CAGR, reinforcing 3M's strong foothold.
Medtronic secures third place, thanks to its significant share in wound closure products like sutures, staplers, and ligating clips, which account for over a quarter of that market segment. Despite limited activity in other areas, Medtronic's position in wound closure ensures its market strength.
MARKET SEGMENTATION OVERVIEW:
Wound Closure Market: Includes sutures, staplers, ligating clips, skin closure strips, mesh, and cyanoacrylate-based tissue adhesives.
Traditional Wound Dressings: Comprises gauze, tapes, bandages (excluding compression types), and cotton-based products.
Landscape, SWOT, Mergers & Acquisitions, FDA Recalls, Disruptive Technologies,
Disease Insights
Data Sources: Interviews with industry experts, government and regulatory data, hospital statistics, import/export records, and internal iData Research databases.
TABLE OF CONTENT
TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. Wound and Tissue Management Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE U.S. Wound and tissue management Market
2.1 Introduction
2.2 Analysis By Market Segment
2.2.1 Worst Case Scenario
2.2.2 Base Case Scenario
2.2.3 Best Case Scenario
Disease Overview
3.1 Disease Treatment and Diagnostic
3.1.1 Vascular Malformations
3.1.2 Deep Ven Thrombosis and Pulmonary Embolism
3.1.3 Lower Extremity Ulcers
3.1.4 Lymphedema
3.1.5 Surgery
3.1.6 Traumas and Burns
3.2 Patient Demographics
3.2.1 Vascular Malformations
3.2.2 Deep Vein Thrombosis and Pulmonary Embolism
3.2.3 Lower Extremity Ulcers
3.2.4 Lymphedema
3.2.5 Traumas and Burns
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Wound Closure Devices
4.2.1.1 Sutures
4.2.1.2 Staplers
4.2.1.3 Ligating Clip Appliers
4.2.1.4 Wound Closure Strips
4.2.1.5 Tissue Adhesives
4.2.2 Traditional Wound Dressings
4.2.3 Advanced Wound Dressings
4.2.4 Moist Dressings
4.2.4.1.1 Foam Dressings
4.2.4.1.2 Transparent Film Dressings
4.2.4.1.3 Hydrocolloid Dressings
4.2.4.1.4 Alginate Dressings
4.2.4.1.5 Gelling Fiber Dressings
4.2.4.1.6 Hydrogel Dressings
4.2.5 Antimicrobial Dressings
4.2.5.1.1 Silver Dressing
4.2.5.1.2 Non-Silver Dressing
4.2.5.1.3 Charcoal Dressing
4.2.6 Interactive Dressing
4.2.6.1.1 Bioactive Dressings
4.2.6.1.2 Skin Substitute
4.2.7 Non-Adherent Contact Layer
4.2.8 Surgical Hemostats
4.2.8.1 Thrombin-Based Hemostats
4.2.8.2 Oxidized Regenerated Cellulose Hemostats
4.2.8.3 Gelatin-Based Hemostat
4.2.8.4 Collagen-Based Hemostat
4.2.8.5 Combination Hemostat
4.2.8.6 Polysaccharide-Based Hemostat
4.2.8.7 First-Responder Hemostat
4.2.9 Tissue Sealants
4.2.9.1 Fibrin-Based Tissue Sealants
4.2.9.2 Protein-Based Tissue Sealants
4.2.9.3 Synthetic Tissue Sealants
4.2.10 Anti-Adhesion
4.2.11 Negative Pressure Wound Therapy
4.2.12 Static Compression Therapy
4.2.12.1 Compression Stockings
4.2.12.2 Anti-Embolism Stockings
4.2.12.3 Compression Bandages
4.2.12.4 Unna Boots
4.2.13 Dynamic Compression Therapy
4.2.13.1 Dynamic DVT Prevention
4.2.13.2 Mobile DVT Prevention
4.2.13.3 Pneumatic Compression
4.3 Regulatory Issues and Recalls
4.3.1 Wound Closure Market FDA Recalls
4.3.2 Moist Dressing Market FDA Recalls
4.3.3 Antimicrobial Dressing Market FDA Recalls
4.3.4 Interactive Dressing Market FDA Recalls
4.3.5 Surgical Hemostat Market FDA Recalls
4.3.6 Tissue Sealant Market FDA Recalls
4.3.7 Anti-Adhesion Market FDA Recalls
4.3.8 Negative Pressure Market FDA Recalls
4.3.9 Static Compression Therapy Market FDA Recalls